These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27133520)

  • 21. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
    Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
    Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.
    Morris MD; Brown B; Allen SA
    Int J Prison Health; 2017 Sep; 13(3-4):192-199. PubMed ID: 28914118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
    Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
    Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on Integrated HIV and Hepatitis C Virus Testing Among Persons Entering a Northern California Jail: A Pilot Study.
    Ly W; Cocohoba J; Chyorny A; Halpern J; Auerswald C; Myers J
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):214-220. PubMed ID: 29474267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection in chronic liver disease in Natal.
    Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
    S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case-control study.
    Chang SS; Hu HY; Chen YC; Yen YF; Huang N
    BMC Gastroenterol; 2022 Sep; 22(1):425. PubMed ID: 36115934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery.
    Assoumou L; Thormann F; Soulié C; Caby F; Dudoit Y; Marcelin AG; Goudot P; Blanc C; Coriat P; Katlama C; Costagliola D; Pourcher V
    HIV Med; 2019 May; 20(5):353-358. PubMed ID: 30924598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
    J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.
    Williams B; Howell J; Doyle J; Thompson AJ; Draper B; Layton C; Latham N; Bramwell F; Membrey D; Mcpherson M; Roney J; Stoové M; Hellard ME; Pedrana A
    Int J Drug Policy; 2019 Oct; 72():91-98. PubMed ID: 31129023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis C: epidemiology natural course and diagnosis].
    Moradpour D; Müllhaupt B
    Rev Med Suisse; 2015 Apr; 11(471):896-901. PubMed ID: 26072594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.
    Enkelmann J; Gassowski M; Nielsen S; Wenz B; Roß S; Marcus U; Bremer V; Zimmermann R;
    Harm Reduct J; 2020 Jan; 17(1):7. PubMed ID: 31924208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.
    Stämpfli D; Imfeld-Isenegger TL; Hersberger KE; Messerli M
    BMC Infect Dis; 2023 Jun; 23(1):384. PubMed ID: 37286975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
    Kamga Wouambo R; Panka Tchinda G; Kagoue Simeni LA; Djouela Djoulako PD; Yateu Wouambo CI; Tamko Mella GF; Tchoumi Leuwat EP; Bello D; Fokam J
    BMC Infect Dis; 2023 Dec; 23(1):875. PubMed ID: 38093205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.